Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	496	406	108	125	256	297
Market Cap Growth	22.35%	277.18%	-14.15%	-50.96%	-14.02%	15.84%
Enterprise Value	435	377	85	117	226	284
Last Close Price	6.19	5.30	1.43	1.68	3.74	4.80
PE Ratio	26.35	47.50	-	-	-	-
Forward PE	27.07	50.28	-	-	-	-
PS Ratio	3.89	4.08	1.29	1.74	3.79	5.02
PB Ratio	7.00	8.81	3.78	4.37	8.06	18.11
P/TBV Ratio	7.04	8.88	3.85	4.48	8.29	19.39
P/FCF Ratio	23.44	33.99	15.45	-	-	-
P/OCF Ratio	23.16	33.54	15.13	-	-	-
EV/Sales Ratio	3.49	3.78	1.01	1.62	3.35	4.79
EV/EBITDA Ratio	21.65	44.12	-	-	-	-
EV/EBIT Ratio	22.52	48.76	-	-	-	-
EV/FCF Ratio	20.55	31.54	12.17	-	-	-
Debt / Equity Ratio	0.04	0.06	0.12	0.15	0.15	0.10
Debt / EBITDA Ratio	0.14	0.27	-	-	-	-
Debt / FCF Ratio	0.14	0.22	0.47	-	-	-
Asset Turnover	1.61	1.62	1.53	1.29	1.40	1.51
Inventory Turnover	3.07	3.21	2.25	2.07	2.05	2.07
Quick Ratio	3.23	2.96	1.57	1.61	1.89	1.17
Current Ratio	4.12	3.57	2.40	2.61	2.78	1.96
Return on Equity (ROE)	38.90%	22.94%	-17.29%	-54.77%	-112.68%	-108.09%
Return on Assets (ROA)	15.60%	7.84%	-6.42%	-20.81%	-35.18%	-31.57%
Return on Capital (ROIC)	21.74%	12.00%	-10.82%	-33.57%	-62.10%	-61.70%
Return on Capital Employed (ROCE)	25.60%	15.40%	-16.30%	-51.50%	-67.30%	-90.70%
Earnings Yield	4.12%	2.10%	-4.59%	-13.19%	-10.61%	-6.70%
FCF Yield	4.27%	2.94%	6.47%	-12.31%	-9.61%	-3.60%
Buyback Yield / Dilution	-10.80%	-4.19%	-7.54%	-3.79%	-10.02%	-7.03%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q